循环组蛋白是急性危重症多器官功能障碍综合征的主要介质
该研究结合回顾性临床研究与动物干预实验,探讨循环组蛋白是否为急性危重症多器官功能障碍综合征的主要介质。回顾性分析420例ICU患者(脓毒症140例、严重创伤63例、重症胰腺炎89例、其他128例)显示循环组蛋白与器官损伤标志物及SOFA评分强相关;体外实验显示高组蛋白水平患者血清对多种来源培养细胞有毒性;脓毒症、创伤、胰腺炎动物模型中组蛋白水平与疾病严重度及多器官损伤呈时间相关性;抗组蛋白单链抗体片段和非抗凝肝素可显著减轻小鼠多器官损伤(尤其心、肺)并改善生存。
要点
- 420例ICU患者中循环组蛋白与器官损伤标志物及SOFA评分强相关,提示其可反映疾病严重度。
- 高组蛋白水平患者血清对多种来源培养细胞有毒性,提示对多器官的普遍毒性。
- 脓毒症、创伤、胰腺炎小鼠模型中组蛋白水平与疾病严重度及多器官损伤呈时间相关。
- 抗组蛋白单链抗体片段和非抗凝肝素可显著减轻小鼠多器官损伤(尤其心、肺)并改善生存。
- 作者认为入住ICU时监测组蛋白可提示疾病严重度,抗组蛋白治疗有减轻MODS、改善危重症患者生存的潜力。
适用人群与场景
- ICU患者420例,包括脓毒症140例、严重创伤63例、重症胰腺炎89例及其他入院诊断128例。
- 动物模型:脓毒症、创伤和急性胰腺炎小鼠模型。
处置流程与药物剂量
- 抗组蛋白试剂包括抗组蛋白单链抗体片段和非抗凝肝素,在体外、离体和动物模型中给药,可显著减轻小鼠多器官损伤(尤其心、肺)并改善生存。
研究设计与关键结果
- 研究类型为回顾性临床研究联合动物干预实验,纳入420例ICU患者(脓毒症140例、严重创伤63例、重症胰腺炎89例、其他128例),回顾性分析前瞻性招募的ICU队列。
- 循环组蛋白与器官损伤标志物及序贯器官衰竭评估(SOFA)评分强相关。
- 体外实验显示高组蛋白水平患者血清对多种来源培养细胞有毒性。
- 脓毒症、创伤、胰腺炎动物模型中组蛋白水平与疾病严重度及多器官损伤呈时间相关。
- 抗组蛋白单链抗体片段和非抗凝肝素可显著减轻小鼠多器官损伤(尤其心、肺)并改善生存。
证据类型、等级与局限
- 证据类型:回顾性临床研究联合动物模型干预实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为入住ICU时监测循环组蛋白可提示疾病严重度。
- 作者认为研发抗组蛋白治疗有减轻多器官功能障碍综合征、改善危重症患者生存的巨大潜力。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Multiple organ dysfunction syndrome is characterized by simultaneous multiple organ failure, which is the leading cause of death in acute critically ill patients. However, what mediates multiple organ dysfunction syndrome is not fully understood. The discovery of toxic effects by extracellular histones on different individual organs strongly suggests their involvement in multiple organ dysfunction syndrome. In this study, we investigate whether circulating histones are major mediators of multiple organ dysfunction syndrome in acute critical illnesses.
DESIGN: Combination of retrospective clinical studies and animal models with intervention.
SETTING: ICU in a tertiary hospital and research laboratories.
PATIENTS: Four hundred and twenty ICU patients, including sepsis (140), severe trauma (63), severe pancreatitis (89), and other admission diagnoses (128).
LABORATORY INVESTIGATION: Cells from major organs are treated with calf thymus histones or histone-containing sera. Animal models for sepsis, trauma, and acute pancreatitis are treated with antihistone reagents.
INTERVENTION: Antihistone reagents in in vitro, ex vivo, and animal models.
MEASUREMENT AND MAIN RESULTS: Retrospective analysis of a prospectively recruited ICU cohort demonstrated a strong correlation between circulating histones and organ injury markers and Sequential Organ Failure Assessment scores. Ex vivo experiments showed that patient sera containing high histone levels were toxic to cultured cells from different origins, suggesting their universal toxicity to multiple organs. Animal models of sepsis, trauma, and pancreatitis further demonstrated a temporal correlation between histone levels and disease severity and multiple organ injury. Importantly, antihistone reagents, that is, antihistone single-chain variable fragment and nonanticoagulant heparin, could dramatically reduce multiple organ injury, particularly of the heart and lungs, and improve survival in mouse models.
CONCLUSIONS: High levels of circulating histones are major mediators of multiple organ dysfunction syndrome. Our results indicate that monitoring upon ICU admission could inform on disease severity and developing antihistone therapy holds great potential of reducing multiple organ dysfunction syndrome and improving survival of critically ill patients.
参考来源
- Cheng Z, Abrams ST, Alhamdi Y, et al. Circulating Histones Are Major Mediators of Multiple Organ Dysfunction Syndrome in Acute Critical Illnesses. Crit Care Med. 2019. PMID: 31162199. doi:10.1097/CCM.0000000000003839
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。